Federal Register of Legislation - Australian Government

Primary content

Determinations/Health as amended, taking into account amendments up to National Health (Residential Medication Chart) Amendment Determination 2014 (No. 1) (No. PB 24 of 2014)
Administered by: Health
Registered 05 Jun 2014
Start Date 01 Jun 2014
End Date 01 Apr 2015
Date of repeal 01 Apr 2015
Repealed by National Health (Residential Medication Chart) (Repeal) Determination 2015 (PB 20 of 2015)

Description: Commonwealth Coat of Arms

National Health (Residential Medication Chart) Determination 2012

as amended

made under subsection 93A(2) of the

National Health Act 1953

Compilation start date:                     1 June 2014

Includes amendments up to:            PB 24 of 2014

 

About this compilation

This compilation

This is a compilation of the National Health (Residential Medication Chart) Determination 2012 as in force on 1 June 2014. It includes any commenced amendment affecting the legislation to that date.

This compilation was prepared on 4 June 2014.

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of each amended provision.

Uncommenced amendments

The effect of uncommenced amendments is not reflected in the text of the compiled law but the text of the amendments is included in the endnotes.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Modifications

If a provision of the compiled law is affected by a modification that is in force, details are included in the endnotes.

Provisions ceasing to have effect

If a provision of the compiled law has expired or otherwise ceased to have effect in accordance with a provision of the law, details are included in the endnotes.

  

  

  


Contents

Part 1—Preliminary                                                                                                                                        1

1.01....... Name of determination.................................................................................................. 1

1.02....... Commencement............................................................................................................. 1

1.03....... Definitions..................................................................................................................... 1

1.04....... Purpose......................................................................................................................... 2

1.05....... Application.................................................................................................................... 2

1.06....... Applicable pharmaceutical benefits................................................................................ 2

Part 2—Conditions                                                                                                                                          4

2.01....... General.......................................................................................................................... 4

2.02....... Conditions—standard fields.......................................................................................... 4

2.03....... Standard fields information—residential care service patients....................................... 5

2.04....... Standard fields information—residential care services.................................................. 5

2.05....... Standard fields information―commencement and expiry dates.................................... 5

2.06....... Standard fields information—privacy notice................................................................. 5

2.07....... Standard fields information—medical practitioners....................................................... 6

2.08....... Standard fields information—regularly administered pharmaceutical benefits............... 6

2.09....... Standard fields information—insulin pharmaceutical benefits (non‑PRN) and blood glucose level (BGL) recording...................................................................................................................................... 8

2.09A.... Standard fields information—insulin PRN (as required) pharmaceutical benefits......... 9

2.10....... Standard fields information—PRN (as required) pharmaceutical benefits..................... 9

2.11....... Standard fields information—pharmaceutical benefits: short‑term medicines.............. 10

2.12....... Standard fields information—variable dose pharmaceutical benefits (non‑insulin)..... 10

2.12A.... Standard fields information―nutritional supplements pharmaceutical benefits........... 11

2.13....... Conditions—characteristics of certain standard fields................................................. 11

2.14....... Conditions—completing certain standard fields before supply of pharmaceutical benefit....... 12

Endnotes                                                                                                                                                               14

Endnote 1—About the endnotes                                                                                                      14

Endnote 2—Abbreviation key                                                                                                          15

Endnote 3—Legislation history                                                                                                       16

Endnote 4—Amendment history                                                                                                     17

Endnote 5—Uncommenced amendments [none]                                                                     18

Endnote 6—Modifications [none]                                                                                                   18

Endnote 7—Misdescribed amendments [none]                                                                        18

Endnote 8—Miscellaneous [none]                                                                                                  18

 


Part 1Preliminary

  

1.01  Name of determination

                   This determination is the National Health (Residential Medication Chart) Determination 2012.

1.02  Commencement

                   This determination commences on 10 July 2012.

1.03  Definitions

                   In this determination:

Act means the National Health Act 1953.

applicable pharmaceutical benefit—see section 1.06.

authority prescription has the meaning given by the Regulations.

Chief Executive Medicare has the meaning given by the Act.

CTG is an acronym of Closing the Gap.

current Poisons Standard has the meaning given by subsection 52A(1) of the Therapeutic Goods Act 1989.

healthcare identifier has the meaning given by the Healthcare Identifiers Act 2010.

multi‑dose pack means a tamper‑evident adherence device which is capable of storing, in separate dosage compartments arranged according to a daily dose schedule, one or more drugs or medicinal preparations that have been removed from the manufacturer’s original packaging.

PBS prescriber number means a PBS prescriber number issued by the Chief Executive Medicare.

Regulations means the National Health (Pharmaceutical Benefits) Regulations 1960.

residential care has the meaning given by section 41–3 of the Aged Care Act 1997.

residential care service has the meaning given by Schedule 1 to the Aged Care Act 1997.

residential medication chart has the meaning given by the Regulations.

Streamlined Authority Code has the meaning given by the National Health (Listing of Pharmaceutical Benefits) Instrument 2010.

Note:          For the definitions of the following terms, see Part VII of the Act:

·      approved medical practitioner

·      approved pharmacist

·      pharmaceutical benefit.

1.04  Purpose

                   This determination sets out:

                     (a)  the pharmaceutical benefits that may be supplied to a patient receiving residential care in a residential care service, using a copy of a residential medication chart for the patient; and

                     (b)  the conditions under which an approved medical practitioner or an approved pharmacist may supply the pharmaceutical benefits, using a copy of a residential medication chart, to a residential care service.

1.05  Application

                   This determination applies to a supply of a pharmaceutical benefit or class of pharmaceutical benefits mentioned in section 1.06 if the supply is made:

                     (a)  using a copy of a residential medication chart; and

                     (b)  to a residential care service by an approved medical practitioner or an approved pharmacist; and

                     (c)  for a patient receiving residential care in a residential care service.

Note:          Paragraphs 93A(2)(a) and (b) of the Act mention ‘prescribed institutions’. Paragraph (b) of the definition of prescribed institution in subsection 93A(1) of the Act refers to a residential care service within the meaning of the Aged Care Act 1997. Also see the note to subsection 93A(2) of the Act.

1.06  Applicable pharmaceutical benefits

             (1)  For paragraph 93A(2)(a) of the Act, the applicable pharmaceutical benefits are those that are generally available for supply under Part VII of the Act.

             (2)  However, the applicable pharmaceutical benefits do not include a pharmaceutical benefit or class of pharmaceutical benefits:

                     (a)  that is mentioned in Schedule 8 to the current Poisons Standard; or

                     (b)  that is available for supply only under a special arrangement made by the Minister in accordance with section 100 of the Act; or

                     (c)  that is available for supply only under a special arrangement made by the           Minister in accordance with section 100 of the Act, in circumstances determined by the Minister under paragraph 85(8)(b) of the Act; or

                     (d)  that a medical practitioner prescribes, using an authority prescription, for a patient receiving residential care in a residential care service.

             (3)  Paragraph (2)(d) does not apply to a pharmaceutical benefit or class of pharmaceutical benefits if a situation exists in which the pharmaceutical benefit or class of pharmaceutical benefits:

                     (a)  has no authority requirements; or

                     (b)  has authority requirements that include a Streamlined Authority Code.

Note 1:       The Poisons Standard 2012 is available on the internet at www.comlaw.gov.au.

Note 2:       Paragraphs 93A(2)(a) and (b) of the Act mention ‘prescribed institutions’. Paragraph (b) of the definition of prescribed institution is in subsection 93A(1) of the Act and refers to a residential care service within the meaning of the Aged Care Act 1997. Also see the note to subsection 93A(2) of the Act.

Part 2Conditions

  

2.01  General

                   This Part:

                     (a)  is made for paragraph 93A(2)(b) of the Act; and

                     (b)  sets out the conditions under which pharmaceutical benefits may be supplied to a residential care service.

Note 1:       Section 1.05 sets out when this determination applies to a supply of pharmaceutical benefits.

Note 2:       Paragraphs 93A(2)(a) and (b) of the Act mention ‘prescribed institutions’. Paragraph (b) of the definition of prescribed institution in subsection 93A(1) of the Act refers to a residential care service within the meaning of the Aged Care Act 1997. Also see the note to subsection 93A(2) of the Act.

2.02  Conditions—standard fields

             (1)  The standard fields on a residential medication chart must include the standard fields mentioned in:

                     (a)  sections 2.03 to 2.07; and

                    (aa)  for an applicable pharmaceutical benefit to which section 2.08 applies—section 2.08; and

                     (b)  for an applicable pharmaceutical benefit to which section 2.09 applies—section 2.09; and

                   (ba)  for an applicable pharmaceutical benefit to which section 2.09A applies—section 2.09A; and

                     (c)  for an applicable pharmaceutical benefit to which section 2.10 applies—section 2.10; and

                     (d)  for an applicable pharmaceutical benefit to which section 2.11 applies—section 2.11; and

                     (e)  for an applicable pharmaceutical benefit to which section 2.12 applies—section 2.12; and

                    (ea)  for an applicable pharmaceutical benefit to which section 2.12A applies—section 2.12A.

             (2)  Also, the standard fields on a residential medication chart must have the characteristics mentioned in:

                     (a)  if the standard field is of a kind mentioned in subparagraphs 2.03(a)(i) to (v) or paragraphs 2.03(b) and (c) or paragraphs 2.04(a) and (c)—subsection 2.13(1); and

                     (b)  if the standard field is of a kind mentioned in section 2.05—subsection 2.13(2); and

                     (c)  if the standard field is for insulin—subsections 2.13(3) and (4); and

                     (d)  if the standard field is for an applicable pharmaceutical benefit that is required to be administered in variable doses—subsection 2.13(5).

2.03  Standard fields information—residential care service patients

                   The standard fields for a patient who is receiving residential care in a residential care service must include a standard field for:

                     (a)  the patient’s:

                              (i)  full name; and

                             (ii)  preferred name (if any); and

                            (iii)  date of birth; and

                            (iv)  Unit Record Number (URN) or Medical Record Number (MRN), expressed as ‘URN/MRN’; and

                             (v)  healthcare identifier; and

                            (vi)  Medicare number; and

                     (b)  the patient’s allergies, including:

                              (i)  the drug or other substance that causes the allergic reaction; and

                             (ii)  the date, type and description of each allergic reaction; and

                     (c)  the patient’s adverse drug reactions, including:

                              (i)  the drug or other substance that causes the adverse drug reaction; and

                             (ii)  the date, type and description of each adverse drug reaction; and

                     (d)  any number specified on a card, issued by the Commonwealth, as an entitlement number (however described) for the patient.

2.04  Standard fields information—residential care services

                   The standard fields for a residential care service must include a standard field for the residential care service’s:

                     (a)  business name; and

                     (b)  business address; and

                     (c)  Residential Aged Care Service ID.

Note:          To identify a Residential Aged Care Service ID, you may choose to use the search feature available on the website for the Aged Care Standards and Accreditation Agency www.accreditation.org.au. Type in the name of the residential care service and click on the button to start the search—a report on the residential care service (if available), including its Residential Aged Care Service ID, will appear.

2.05  Standard fields information―commencement and expiry dates

                   The standard fields for the period of validity of the residential medication chart must include a standard field for the chart’s:

                     (a)  commencement date; and

                     (b)  expiry date.

2.06  Standard fields information—privacy notice

                   The standard fields for a privacy notice must include:

                     (a)  privacy information of the kind included on a prescription; and

                     (b)  a reference to the Privacy Act 1988.

2.07  Standard fields information—medical practitioners

                   The standard fields for a medical practitioner must include a standard field for the medical practitioner’s:

                     (a)  full name and signature:

                              (i)  on the front page of the residential medication chart for a patient; and

                             (ii)  for each pharmaceutical benefit that the medical practitioner prescribes for the patient using the residential medication chart; and

                     (b)  address; and

                     (c)  PBS prescriber number; and

                     (d)  contact details sufficient to make contact with the practitioner at any time.

Note:          Paragraph (a) of the definition of PBS prescriber in Part VII of the Act includes a medical practitioner.

2.08  Standard fields information—regularly administered pharmaceutical benefits

             (1)  The standard fields for a regularly administered applicable pharmaceutical benefit must include a standard field for:

                     (a)  particulars sufficient to identify the applicable pharmaceutical benefit, including the name, pharmaceutical dose form and strength, expressed as ‘medicine/form/strength’; and

                     (b)  the applicable pharmaceutical benefit’s:

                              (i)  date of prescribing; and

                             (ii)  dose; and

                            (iii)  route of administration; and

                            (iv)  frequency of administration; and

                     (c)  the day, month and year of the date (the start date) to start administering the pharmaceutical benefit; and

                     (d)  the day, month and year of the date (the stop date) to stop administering the pharmaceutical benefit; and

                     (e)  a check box next to the words ‘Valid for duration of chart’; and

                      (f)  a check box next to the words ‘Brand substitution not permitted’; and

                     (g)  a check box next to the expression ‘CTG’; and

                     (h)  the expression ‘PBS/RPBS’; and

                      (i)  the words ‘Streamlined Authority Code’ and (immediately next to those words) 4 empty boxes, with each box being large enough for a single digit number to be clearly written in the box; and

                    (ia)  additional instructions (if any) to be added by the medical practitioner, expressed as ‘Additional instructions’; and

                      (j)  a box next to the heading, enclosing the name of each calendar month; and

                              (i)  next to a box enclosing the words ‘Date’ and ‘Times’―a numbered box for each day of each month, laid out on the page horizontally and numbered consecutively, beginning with ‘1’ and ending with ‘31’; and

                             (ii)  under the box enclosing the words ‘Date’ and ‘Times’—a column of several boxes, laid out on the page vertically, with each box being empty and large enough for the time the applicable pharmaceutical benefit is administered, if not administered by means of a multi‑dose pack, to be clearly written in the box; and

                            (iii)  next to the column of empty boxes mentioned in subparagraph  (ii)—several rows of boxes, laid out on the page horizontally, with each box being large enough for the initials of the person who administered the pharmaceutical benefit to be clearly written in the box.

             (2)  The standard fields for a regularly administered applicable pharmaceutical benefit must also include a standard field to record the administration of the benefit if the benefit has been administered by means of a multi‑dose pack, being:

                     (a)  a box enclosing the name of each calendar month; and:

                              (i)  next to a box enclosing the words ‘Date’ and ‘Times’―a numbered box for each day of each month, laid out on the page horizontally and numbered consecutively, beginning with ‘1’ and ending with ‘31’; and

                             (ii)  under the box enclosing the words ‘Date’ and ‘Times’―a column of several boxes, laid out on the page vertically, with:

                                        (A)  a box including the word ‘Breakfast’; and

                                        (B)  below that, a box including the word ‘Lunch’; and

                                        (C)  below that, a box including the word ‘Dinner’; and

                                        (D)  below that, a box including the word ‘Bed time’; and

                                         (E)  each other box being empty and large enough for the time when the applicable pharmaceutical benefit is administered as part of the multi‑dose pack to be clearly written in the box; and

                            (iii)  next to the column of boxes mentioned in subparagraph (ii)―several rows of boxes, laid out on the page horizontally, with each box being large enough for the initials of the person who administered the pharmaceutical benefit as part of the multi‑dose pack to be clearly written in the box.

             (3)  For paragraphs (1)(j)(iii) and (2)(a)(iii), there must be enough rows and enough boxes in the rows to allow the administration of the pharmaceutical benefit to be recorded for each day of the 4 month period of validity of the residential medication chart.

             (4)  For the standard fields mentioned in subparagraphs (2)(a)(ii), the boxes mentioned in sub‑subparagraphs 2(a)(ii)(A) to (D) may be preceded, separated or followed by one or more of the empty boxes mentioned in sub‑subparagraph 2(a)(ii)(E).

             (5)  For the standard fields at paragraphs (1)(d) and (e), the fields must be enclosed in the same box and clearly presented as being mutually exclusive.

Note 1:       See section 2.05 for the requirements for the standard field for the expiry date of a residential medication chart.

Note 2:       For a provision that may affect whether the special patient contribution mentioned in subsection 85B(4) of the Act is payable by the Commonwealth if the Streamlined Authority Code is not written in the related section of the chart, see subsection 85B(5) of the Act.

2.09  Standard fields information—insulin pharmaceutical benefits (non‑PRN) and blood glucose level (BGL) recording

             (1)  The standard fields for an applicable pharmaceutical benefit that is insulin that is not required to be administered PRN (as required) must include standard fields for:

                     (a)  the information mentioned in subsection 2.08(1), other than subparagraphs 2.08(1)(b)(ii) and (iv) and paragraphs 2.08(1)(f), (i) and (j); and

                    (aa)  the applicable pharmaceutical benefit’s dose, which must include the word ‘units’; and

                   (ab)  the applicable pharmaceutical benefit’s time of administration; and

                     (b)  a row of boxes, laid out on the page horizontally, with:

                              (i)  the first box enclosing the word ‘Time’; and

                             (ii)  each other box being empty and large enough for the time at which the patient’s blood glucose level is monitored to be clearly written in the box; and

                     (c)  immediately under the row of boxes mentioned in paragraph (b)—a row of boxes, laid out on the page horizontally, with:

                              (i)  the first box enclosing the acronym ‘BGL’; and

                             (ii)  each other box being empty and large enough for patient’s blood glucose level to be clearly written in the box; and

                     (d)  a row of boxes, laid out on the page horizontally, with:

                              (i)  the first box enclosing the words ‘Time’; and

                             (ii)  each other box being empty and large enough for the time at which the pharmaceutical benefit is administered to be clearly written in the box; and

                     (e)  immediately under the row of boxes mentioned in paragraph (d)—a row of boxes, laid out on the page horizontally, with:

                              (i)  the first box enclosing the words ‘Dose’; and

                             (ii)  each other box enclosing the word ‘units’ and being large enough for the dose, in units, to be clearly written in the box; and

                      (f)  immediately under the row of boxes mentioned in paragraph (e)—a row of boxes, laid out on the page horizontally, with:

                              (i)  the first box enclosing the term ‘Initial 1’; and

                             (ii)  each other box being empty and large enough for the initials of the person who administers the pharmaceutical benefit to be clearly written in the box; and

                     (g)  immediately under the row of boxes mentioned in paragraph (f)―a row of boxes, laid out on the page horizontally, with:

                              (i)  the first box enclosing the term ‘Initial 2’; and

                             (ii)  each other box being empty and large enough for the initials of the person who administers the pharmaceutical benefit to be clearly written in the box.

             (2)  For paragraph (1)(ab) to (g), there must be enough rows and enough boxes in the rows to allow the administration of the pharmaceutical benefit to be recorded for each day of the 4 month period of validity of the residential medication chart.

Note:          See section 2.05 for the requirements for the standard field for the expiry date of a residential medication chart.

2.09A  Standard fields information—insulin PRN (as required) pharmaceutical benefits

             (1)  The standard fields for an applicable pharmaceutical benefit that is insulin that is required to be administered PRN (as required) must include standard fields for:

                     (a)  the information mentioned in paragraphs 2.08(1)(a), (c), (d), (e), (g) and (h), and paragraph 2.08(1)(b) other than subparagraph (iv).

                     (b)  the applicable pharmaceutical benefit’s time of administration; and

                     (c)  the expression ‘Max dose/24hr’; and

                     (d)  a column of 4 boxes, laid out on the page vertically, with:

                              (i)  the first box enclosing the word ‘Date’; and

                             (ii)  the second box enclosing the word ‘Time’: and

                            (iii)  the third box enclosing the word ‘Dose’; and

                            (iv)  the fourth box enclosing the word ‘Initial’; and

                     (e)  4 rows of empty boxes next to the column of 4 boxes mentioned in paragraph (d):

                              (i)  laid out on the page horizontally; and

                             (ii)  with each box in each row being large enough for the information mentioned in subparagraph (d)(i), (ii), (iii) or (iv) to be clearly written in the box.

2.10  Standard fields information—PRN (as required) pharmaceutical benefits

                   The standard fields for an applicable pharmaceutical benefit, other than insulin, that is required to be administered PRN (as required) must include standard fields for:

                     (a)  the information mentioned in paragraphs 2.08(1)(a) to (i); and

                     (b)  the word ‘Indication’; and

                     (c)  the expression ‘Max dose/24hr’; and

                     (d)  a column of 4 boxes, laid out on the page vertically, with:

                              (i)  the first box enclosing the word ‘Date’; and

                             (ii)  the second box enclosing the word ‘Time’; and

                            (iii)  the third box enclosing the word ‘Dose’; and

                            (iv)  the fourth box enclosing the word ‘Initial’; and

                     (e)  4 rows of empty boxes next to the column of 4 boxes mentioned in paragraph (d):

                              (i)  laid out on the page horizontally; and

                             (ii)  with each box in each row being large enough for the information mentioned in subparagraph (d)(i), (ii), (iii) or (iv) to be clearly written in the box.

2.11  Standard fields information—pharmaceutical benefits: short‑term medicines

                   The standard fields for an applicable pharmaceutical benefit that is a short‑term medicine must include standard fields for the information mentioned in paragraphs 2.08(1)(a) to (d) and (f) to (j), other than subparagraph 2.08(1)(j)(i).

Note:          See section 2.05 for the requirements for the standard field for the expiry date of a residential medication chart.

2.12  Standard fields information—variable dose pharmaceutical benefits (non‑insulin)

             (1)  The standard fields for an applicable pharmaceutical benefit, other than insulin, that can be administered in variable doses must include standard fields for:

                     (a)  the information mentioned in subsection 2.08(1), other than paragraph 2.08(1)(j); and

                    (aa)  a box enclosing the name of each calendar month; and

                   (ab)  next to a box enclosing the word ‘Date’―a numbered box for each day of each month, laid out on the page horizontally and numbered consecutively, beginning with ‘1’ and ending with ‘31’; and

                     (b)  a row of boxes, laid out on the page horizontally, with:

                              (i)  the first box enclosing the words ‘Pathology result’; and

                             (ii)  each other box being empty and large enough for the pathology result to be clearly written in the box; and

                     (c)  immediately under the row of boxes mentioned in paragraph (b)—a row of boxes, laid out on the page horizontally, with:

                              (i)  the first box enclosing the words ‘Dose prescribed’; and

                             (ii)  each other box being large enough for the dose prescribed to be clearly written in the box; and

                     (d)  a row of boxes, laid out on the page horizontally, with:

                              (i)  the first box enclosing the words ‘Dose given’; and

                             (ii)  each other box being large enough for the dose given to be clearly written in the box; and

                   (da)  a row of boxes, laid out horizontally, with:

                              (i)  the first box enclosing the word ‘Time’; and

                             (ii)  each other box being empty and large enough for the time at which the pharmaceutical benefit is administered to be clearly written in the box; and

                     (e)  a row of boxes, laid out horizontally, with:

                              (i)  the first box enclosing the term ‘Initial 1’; and

                             (ii)  each other box being empty and large enough for the initials to be clearly written in the box; and

                      (f)  a row of boxes, laid out horizontally, with:

                              (i)  the first box enclosing the term ‘Initial 2’; and

                             (ii)  each other box being empty and large enough for the initials to be clearly written in the box.

             (2)  For paragraph (1)(b) to (f), there must be enough rows and enough boxes in the rows to allow the administration of the pharmaceutical benefit to be recorded for each day of the 4 month period of validity of the residential medication chart.

Note:          See section 2.05 for the requirements for the standard field for the expiry date of a residential medication chart.

2.12A  Standard fields information―nutritional supplements pharmaceutical benefits

             (1)  The standard fields for an applicable pharmaceutical benefit that is a nutritional supplement must include standard fields for:

                     (a)  particulars sufficient to identify the applicable pharmaceutical benefit, including the name and strength, expressed as ‘nutritional supplement’; and

                     (b)  the applicable pharmaceutical benefit’s:

                              (i)  date of prescribing; and

                             (ii)  dose; and

                            (iii)  route of administration; and

                            (iv)  frequency of administration; and

                     (c)  the day, month and year of the date (the start date) to start administering the pharmaceutical benefit; and

                     (d)  the day, month and year of the date (the stop date) to stop administering the pharmaceutical benefit; and:

                     (e)  a check box next to the words ‘Valid for duration of chart’; and

                      (f)  a check box next to the words ‘Brand substitution not permitted’; and

                     (g)  a check box next to the expression ‘CTG’; and

                     (h)  the expression ‘PBS/RPBS’; and

                      (i)  additional instructions (if any) to be added by the medical practitioner, expressed as ‘Additional instructions’.

2.13  Conditions—characteristics of certain standard fields

             (1)  The standard fields mentioned in the following provisions must be easily readable and clearly visible to a person looking at any page of the residential medication chart:

                     (a)  subparagraphs 2.03(a)(i) to (v);

                     (b)  paragraphs 2.03(b) and (c) and 2.04(a) and (c).

             (2)  The standard fields for the commencement date and expiry date mentioned in section 2.05 must be on the front page of the residential medication chart.

             (3)  The standard fields for a pharmaceutical benefit that is insulin must be in a part of the residential medication chart that relates only to insulin.

             (4)  The standard field for the patient’s blood glucose level must be clearly visible to a person    looking at the standard fields for administering insulin.

             (5)  The standard fields for a pharmaceutical benefit that is required to be administered in variable doses must be in a part of the residential medication chart that relates only to that pharmaceutical benefit.

2.14  Conditions—completing certain standard fields before supply of pharmaceutical benefit

                   An approved medical practitioner, or an approved pharmacist, must not supply an applicable pharmaceutical benefit unless:

                     (a)  an individual has completed the following standard fields:

                              (i)  the patient’s full name, mentioned in subparagraph 2.03(a)(i);

                             (ii)  the Residential Aged Care Service ID of the residential care service in which the patient resides, mentioned in paragraph 2.04(c).

                            (iii)  the medical practitioner’s full name, mentioned in paragraph 2.07(a);

                            (iv)  the medical practitioner’s address, mentioned in paragraph 2.07(b);

                             (v)  the medical practitioner’s PBS prescriber number, mentioned in paragraph 2.07(c); and

                     (b)  a medical practitioner has completed the following standard fields in the way described (if any) for the standard field:

                              (i)  the particulars sufficient to identify the applicable pharmaceutical benefit, expressed as ‘medicine/form/strength’ and mentioned in paragraph 2.08(1)(a);

                             (ii)  the date of prescribing the applicable pharmaceutical benefit, mentioned in subparagraph 2.08(1)(b)(i);

                            (iii)  the dose of the applicable pharmaceutical benefit, mentioned in subparagraph 2.08(1)(b)(ii);

                            (iv)  if applicable—the start date, mentioned in paragraph 2.08(1)(c); and

                             (v)  if applicable—the stop date, mentioned in paragraph 2.08(1)(d); and

                            (vi)  the route of administration of the applicable pharmaceutical benefit, mentioned in subparagraph 2.08(1)(b)(iii);

                           (vii)  the frequency of administration of the applicable pharmaceutical benefit, mentioned in subparagraph 2.08(1)(b)(iv);

                          (viii)  if applicable—the check box located immediately next to the words ‘Valid for duration of chart’, mentioned in paragraph 2.08(1)(e);

                            (ix)  if applicable—the check box immediately next to the words ‘Brand substitution not permitted’, mentioned in paragraph 2.08(1)(f);

                             (x)  if applicable—the check box immediately next to the expression ‘CTG’, mentioned in paragraph 2.08(1)(g); and

                            (xi)  if applicable—the standard field for the Streamlined Authority Code, mentioned in paragraph 2.08(1)(i);

                           (xii)  the medical practitioner’s signature:

                                        (A)  on the front page of the residential medication chart for a patient, mentioned in subparagraph 2.07(a)(i); and

                                        (B)  for each pharmaceutical benefit that the medical practitioner prescribes for the patient using the residential medication management chart, mentioned in subparagraph 2.07(a)(ii).

Note 1:       Paragraph (a) of the definition of PBS prescriber in Part VII of the Act includes a medical practitioner.

Note 2:       See paragraph (b) of the definition of completed item in a residential medication chart in the Regulations for a requirement related to including the letters ‘PBS’.

Note 3:       Regulation 21A of the Health Insurance (Pharmaceutical Benefits) Regulation 1960 provides that an approved pharmacist or approved medical practitioner may only supply a pharmaceutical benefit on the basis of a residential medication chart if the approved pharmacist or medical practitioner is given a copy of the chart.


Endnotes

Endnote 1—About the endnotes

The endnotes provide details of the history of this legislation and its provisions. The following endnotes are included in each compilation:

 

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Endnote 5—Uncommenced amendments

Endnote 6—Modifications

Endnote 7—Misdescribed amendments

Endnote 8—Miscellaneous

 

If there is no information under a particular endnote, the word “none” will appear in square brackets after the endnote heading.

 

Abbreviation key—Endnote 2

The abbreviation key in this endnote sets out abbreviations that may be used in the endnotes.

 

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

 

The legislation history in endnote 3 provides information about each law that has amended the compiled law. The information includes commencement information for amending laws and details of application, saving or transitional provisions that are not included in this compilation.

 

The amendment history in endnote 4 provides information about amendments at the provision level. It also includes information about any provisions that have expired or otherwise ceased to have effect in accordance with a provision of the compiled law.

 

Uncommenced amendments—Endnote 5

The effect of uncommenced amendments is not reflected in the text of the compiled law but the text of the amendments is included in endnote 5.

 

Modifications—Endnote 6

If the compiled law is affected by a modification that is in force, details of the modification are included in endnote 6.

 

Misdescribed amendments—Endnote 7

An amendment is a misdescribed amendment if the effect of the amendment cannot be incorporated into the text of the compilation. Any misdescribed amendment is included in endnote 7.

 

Miscellaneous—Endnote 8

Endnote 8 includes any additional information that may be helpful for a reader of the compilation.

Endnote 2—Abbreviation key

 

ad = added or inserted

pres = present

am = amended

prev = previous

c = clause(s)

(prev) = previously

Ch = Chapter(s)

Pt = Part(s)

def = definition(s)

r = regulation(s)/rule(s)

Dict = Dictionary

Reg = Regulation/Regulations

disallowed = disallowed by Parliament

reloc = relocated

Div = Division(s)

renum = renumbered

exp = expired or ceased to have effect

rep = repealed

hdg = heading(s)

rs = repealed and substituted

LI = Legislative Instrument

s = section(s)

LIA = Legislative Instruments Act 2003

Sch = Schedule(s)

mod = modified/modification

Sdiv = Subdivision(s)

No = Number(s)

SLI = Select Legislative Instrument

o = order(s)

SR = Statutory Rules

Ord = Ordinance

Sub‑Ch = Sub‑Chapter(s)

orig = original

SubPt = Subpart(s)

par = paragraph(s)/subparagraph(s)
/sub‑subparagraph(s)

 

 

Endnote 3—Legislation history

 

 

Name

FRLI registration

Commencement

Application, saving and transitional provisions

National Health (Residential Medication Chart) Determination 2012

10 July 2012 (see F2012L01526)

10 July 2012

 

 

National Health (Residential Medication Chart) Amendment Determination 2012 (No. 1)
(PB 59 of 2012)

20 Aug 2012 (see F2012L01715)

21 Aug 2012

 

National Health (Residential Medication Chart) Amendment Determination 2012 (No. 2)
(PB 101 of 2012)

7 Nov 2012 (see F2012L02154)

8 Nov 2012

 

National Health (Residential Medication Chart) Amendment Determination 2013 (No. 1)
(PB 52 of 2013)

23 July 2013 (see F2013L01416)

1 Aug 2013

 

National Health (Residential Medication Chart) Amendment Determination 2014 (No. 1)
(PB 24 of 2014)

30 May 2014 (see F2014L00634)

1 June 2014

 

 

Endnote 4—Amendment history

 

Provision affected

How affected

Pt 1

 

s 1.03................................

am PB 24 of 2014

Pt 2

 

s 2.02................................

am PB 24 of 2014

s 2.05................................

rs PB 24 of 2014

s 2.07................................

am PB 24 of 2014

s 2.08................................

am PB 59 of 2012

 

rs PB 24 of 2014

hdg to s 2.09.....................

am PB 24 of 2014

s 2.09................................

am PB 59 of 2012; PB 24 of 2014

s 2.09A.............................

ad PB 24 of 2014

s 2.10................................

am PB 24 of 2014

hdg to s 2.11.....................

ad PB 101 of 2012

s 2.11................................

am PB 59 of 2012; PB 52 of 2013

hdg to s 2.12.....................

am PB 24 of 2014

s 2.12................................

am PB 59 of 2012; PB 24 of 2014

s 2.12A.............................

ad PB 24 of 2014

s 2.13................................

am PB 59 and 101 of 2012; PB 24 of 2014

s 2.14................................

am PB 101 of 2012; PB 24 of 2014

Note 3 to s 2.14................

ad PB 24 of 2014

 

Endnote 5—Uncommenced amendments [none]

Endnote 6—Modifications [none]

Endnote 7—Misdescribed amendments [none]

Endnote 8—Miscellaneous [none]